[1] Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, deVeber G, Ferro JM, Tsai FY; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2011, 42:1158-1192. [2] Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis:results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT)[J]. Stroke, 2004, 35:664-670. [3] Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis:a cross-sectional study[J]. Stroke, 2012, 43:3375-3377. [4] Gunes HN, Cokal BG, Guler SK, Yoldas TK, Malkan UY, Demircan CS, Yon MI, Yoldas Z, Gunes G, Haznedaroglu IC. Clinical associations, biological risk factors and outcomes of cerebral venous sinus thrombosis[J]. J Int Med Res, 2016, 44:1454-1461. [5] Dong Y, Guo ZN, Li Q, Ni W, Gu H, Gu YX, Dong Q; Chinese Stroke Association Stroke Council Guideline Writing Committee. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders:executive summary and 2019 update of clinical management of spontaneous subarachnoid haemorrhage[J]. Stroke Vasc Neurol, 2019, 4:176-181. [6] Cong YW, Wang XF, Dong XH, Qi JP. Superficial vein thrombosis with hemorrhagic cerebral infarction[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16:38-42. [丛玉玮, 王雪峰, 董祥慧, 戚基萍. 大脑浅静脉血栓形成伴出血性脑梗死[J]. 中国现代神经疾病杂志, 2016, 16:38-42.] [7] Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease:an update[J]. J Am Coll Cardiol, 2004, 43:1731-1737. [8] Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis[J]. Clin Radiol, 2002, 57:449-461. [9] Meng R, Konakondla S, Wang X, Lo EH, Ding Y, Ji X. Plasma biomarker may help to distinguish acute CVST from non-thrombotic CVSS in emergency[J]. Int J Stroke, 2012, 7:183-184. [10] Lei XB, Wang XJ. D-dimer detection and its clinical application progress[J]. Yi Xue Zong Shu, 2020, 26:4521-4527. [雷孝波, 王秀杰. D-二聚体检测及其临床应用进展[J]. 医学综述, 2020, 26:4521-4527.] [11] Meng R, Dornbos D 3rd, Meng L, Wu Y, Liu Y, Li G, Li G, Li S, Sun F, Wang X, Ding Y, Ji X. Clinical differences between acute CVST and non-thrombotic CVSS[J]. Clin Neurol Neurosurg, 2012, 114:1257-1262. [12] Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L. Antithrombotic therapy for VTE disease:CHEST guideline and expert panel report[J]. Chest, 2016, 149:315-352. [13] Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC; RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis:a randomized clinical trial[J]. JAMA Neurol, 2019, 76:1457-1465. [14] Stam J. Thrombosis of the cerebral veins and sinuses[J]. N Engl J Med, 2005, 352:1791-1798. [15] Gameiro J, Ferro JM, Canhão P, Stam J, Barinagarrementeria F, Lindgren A; International Study on Cerebral Vein and Dural Sinus Thrombosis investigators. Prognosis of cerebral vein thrombosis presenting as isolated headache:early vs. late diagnosis[J]. Cephalalgia, 2012, 32:407-412. |